Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Ganciclovir Implant

Intraocular implant (Vitrasert) 4.5 mg ganciclovir/implant Idoxuridine (Herplex)... [Pg.1089]

Kappel PJ, Charonis AC, Holland GN, et al. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology. 2006 113 683.el -8. [Pg.543]

Figure 3-19 Cross-section of ganciclovir implant. (Modified from Charles NC, Steiner GC. Ganciclovir intraocular implant. A cHnicopathologic study. Ophthalmology 1996 103 416-421.)... Figure 3-19 Cross-section of ganciclovir implant. (Modified from Charles NC, Steiner GC. Ganciclovir intraocular implant. A cHnicopathologic study. Ophthalmology 1996 103 416-421.)...
Chang M, Dunn JP Ganciclovir implant in the treatment of cytomegalovirus retinitis. Expert Rev Med Devices 2005 2 421-427. [Pg.52]

Dillon B, Kamal A, Leen C. Intravitreal sustained-released ganciclovir implantation to control cytomegalovirus retinitis in AlDS.lntJ STD AIDS 1998 9 227-230. [Pg.52]

Martin DF, Dunn JP Davis JL, et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy recommendations of the international AIDS society—USA panel. Am J Ophthalmol 1999 127 329-339. [Pg.52]

Endophthalmitis with scleral damage has been associated with a ganciclovir implant (9). [Pg.1480]

A 39-year-old woman complained of increasing pain and complete loss of vision in the left eye 1 month after insertion of a ganciclovir implant. The eye was enucleated and pathological examination showed a vitreous abscess the implant suture tab was intrascleraUy located. [Pg.1480]

Treatment options for CMV retinitis include the intra-vitreal insertion of ganciclovir implants. This method of drug delivery has the attraction of avoiding systemic drug toxicity, but the inherent danger of introducing bacterial infection has been highlighted (16). [Pg.1481]

Charles NC, Freisberg L. Endophthalmitis associated with extrusion of a ganciclovir implant. Am J Ophthalmol 2002 133(2) 273-5. [Pg.1481]

Musch D, Martin D, Gordon J, et al. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med 1997 337 83-90. [Pg.2277]

Morley MG, Duker J, Ashton P, Robinson M. Replacing ganciclovir implants. Ophthalmology 1995 102 388-394. [Pg.24]

Figure 9 Photograph of a prepared ganciclovir implant prior to implantation. A hole has been placed in the strut 1.5 mm from the base. The strut has also been trimmed so that the distance from the hole to the end of the strut is no more than 0.5 mm and there are no sharp edges. Figure 9 Photograph of a prepared ganciclovir implant prior to implantation. A hole has been placed in the strut 1.5 mm from the base. The strut has also been trimmed so that the distance from the hole to the end of the strut is no more than 0.5 mm and there are no sharp edges.
Perkins SL, Yang C-H, Ashton PA, Jaffe GJ. Pharmacokinetics of the ganciclovir implant in the silicone-filled eye. Retina 2001 21 10-14. [Pg.223]

McGuire DE, McAuliffe P, Heinemann M-H, Rahhal FM. Efficacy of the ganciclovir implant in the setting of silicone oil vitreous substitute. Retina 2000 20 520-523. [Pg.223]

Martin DF, Ferris FL, Parks DJ, et al. Ganciclovir implant exchange. Timing, surgical procedure, and complications. Arch Ophthalmol 1997 115 1389-1394. [Pg.223]

Browning DJ. Dislocated ganciclovir implant from use of a nylon fixation suture. Retina 2003 23 723-724. [Pg.224]

Lim JI, Wolitz RA, Dowling AH, Bloom HR, Irvine AR, Schwartz DM. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1999 127 288-293. [Pg.224]

Taguri AH, Dhillon B, Wharton SB, Kamal A. Foreign body reaction with delayed extrusion of ganciclovir implant in a patient with immune recovery vitritis syndrome. Am J Ophthalmol 2002 133 147-149. [Pg.224]

Hatton MP, Duker JS, Reichel E, Morley MG, Puliafito CA. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant. Retina 1998 18 50-55. [Pg.224]

Roth DB, Feuer WJ, Blenke AJ, Davis JL. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant. Am J Ophthalmol 1999 127 276-282. [Pg.224]

Boyer DS, Posalski J. Potential complication associated with removal of ganciclovir implants. Am J Ophthalmol 1999 127 349-350. [Pg.224]

Figure 1 (See color insert) The ganciclovir implant. Note the yellow pellet of ganciclovir on the left and the stmt which is secured to the sclera to the right. Figure 1 (See color insert) The ganciclovir implant. Note the yellow pellet of ganciclovir on the left and the stmt which is secured to the sclera to the right.
See other pages where Ganciclovir Implant is mentioned: [Pg.1126]    [Pg.1154]    [Pg.51]    [Pg.52]    [Pg.309]    [Pg.623]    [Pg.773]    [Pg.1481]    [Pg.2272]    [Pg.206]    [Pg.206]    [Pg.213]    [Pg.214]    [Pg.215]    [Pg.327]    [Pg.332]    [Pg.336]    [Pg.337]    [Pg.337]   
See also in sourсe #XX -- [ Pg.94 ]



SEARCH



Ganciclovir

Ganciclovir implants intraocular implant

Ganciclovir intraocular implant

Ganciclovir intravitreal implant with

Intravitreal implant, ganciclovir

Replacement of the Ganciclovir Implant

The Ganciclovir Intraocular Implant

© 2024 chempedia.info